S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:PROG

Progenity Stock Forecast, Price & News

$3.99
-0.06 (-1.48 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.60
Now: $3.99
$4.14
50-Day Range
$4.05
MA: $5.95
$7.31
52-Week Range
$3.08
Now: $3.99
$15.92
Volume526,486 shs
Average Volume608,492 shs
Market Capitalization$217.94 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Progenity, Inc., a biotechnology company, provides complex molecular and specialized testing services to physicians, clinicians, and their patients in the United States. It offers testing services for common hereditary disorders, cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and Jewish genetic diseases; pan-ethnic carrier screening services; non-invasive prenatal, miscarriage, and pharmacogenetic testing services; and ovarian assessment reports for women. The company also provides pediatric testing services. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November, 2013. The company was incorporated in 2012 and is based in San Diego, California with a laboratory in Ann Arbor, Michigan. It has a bill payment location in Detroit, Michigan.
Progenity logo

Headlines

Progenity Secures $25M Via Equity Issued At 5% Discount
February 23, 2021 |  finance.yahoo.com
Progenity Announces $25 Million Private Placement
February 23, 2021 |  finance.yahoo.com
Why Progenity's Stock Is Trading Lower Today
February 10, 2021 |  benzinga.com
Progenity Inc.
February 7, 2021 |  barrons.com
See More Headlines

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PROG
CUSIPN/A
CIKN/A
Phone855-293-2639
Employees702
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$217.94 million
Next Earnings Date3/8/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

2.15 out of 5 stars

Medical Sector

38th out of 1,972 stocks

Medical Laboratories Industry

1st out of 39 stocks

Analyst Opinion: 3.3Community Rank: 3.5Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -
$3.99
-0.06 (-1.48 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PROG News and Ratings via Email

Sign-up to receive the latest news and ratings for PROG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Progenity (NASDAQ:PROG) Frequently Asked Questions

Is Progenity a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Progenity in the last year. There are currently 1 sell rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Progenity stock.
View analyst ratings for Progenity
or view top-rated stocks.

What stocks does MarketBeat like better than Progenity?

Wall Street analysts have given Progenity a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Progenity wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Progenity's next earnings date?

Progenity is scheduled to release its next quarterly earnings announcement on Monday, March 8th 2021.
View our earnings forecast for Progenity
.

How were Progenity's earnings last quarter?

Progenity, Inc. (NASDAQ:PROG) announced its quarterly earnings results on Monday, November, 9th. The company reported ($1.01) EPS for the quarter, missing the consensus estimate of ($0.62) by $0.39. The business had revenue of $25.94 million for the quarter, compared to the consensus estimate of $25.50 million.
View Progenity's earnings history
.

What guidance has Progenity issued on next quarter's earnings?

Progenity issued an update on its FY 2021 After-Hours earnings guidance on Wednesday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $130-145 million, compared to the consensus revenue estimate of $134.54 million.

What price target have analysts set for PROG?

5 Wall Street analysts have issued 1 year target prices for Progenity's stock. Their forecasts range from $5.00 to $12.00. On average, they anticipate Progenity's stock price to reach $9.80 in the next twelve months. This suggests a possible upside of 145.6% from the stock's current price.
View analysts' price targets for Progenity
or view top-rated stocks among Wall Street analysts.

Who are Progenity's key executives?

Progenity's management team includes the following people:
  • Dr. Harry Stylli, Founder, CEO & Chairman (Age 59, Pay $395k)
  • Dr. Matthew T. Cooper M.B.A., Ph.D., Chief Scientific Officer (Age 49, Pay $393.71k)
  • Mr. Sami Shihabi M.B.A., M.S., Chief Commercial Officer (Age 50, Pay $415.52k)
  • Mr. Eric d'Esparbes, Chief Financial Officer (Age 53)
  • Mr. Damon Silvestry, Chief Operating Officer (Age 53)
  • Eric Fox, VP of Fin. & Accounting & Treasurer
  • Mr. Troy Seelye, Chief Information Officer (Age 58)
  • Mr. Clarke Neumann, Sr. VP, Gen. Counsel & Sec. (Age 57)
  • Mr. Hutan Hashemi J.D., Chief Compliance Officer
  • Mr. George Gianakopoulos, Sr. VP of Sales (Age 60)

Who are some of Progenity's key competitors?

What other stocks do shareholders of Progenity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Progenity investors own include Advanced Micro Devices (AMD), Ampio Pharmaceuticals (AMPE), Enphase Energy (ENPH), Kandi Technologies Group (KNDI), Trevena (TRVN), ChromaDex (CDXC), Chimerix (CMRX), CorMedix (CRMD), CTI BioPharma (CTIC) and DRDGOLD (DRD).

When did Progenity IPO?

(PROG) raised $100 million in an initial public offering (IPO) on Friday, June 19th 2020. The company issued 6,700,000 shares at $14.00-$16.00 per share. Piper Sandler and Wells Fargo Securities served as the underwriters for the IPO and Baird, Raymond James and BTIG were co-managers.

What is Progenity's stock symbol?

Progenity trades on the NASDAQ under the ticker symbol "PROG."

Who are Progenity's major shareholders?

Progenity's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (1.16%), Perkins Capital Management Inc. (0.76%), Wells Fargo & Company MN (0.20%), Northern Trust Corp (0.15%), Dupont Capital Management Corp (0.06%) and Paloma Partners Management Co (0.05%). Company insiders that own Progenity stock include Athyrium Capital Management, L, Damon Silvestry, Harry Stylli and Jeffrey D Alter.
View institutional ownership trends for Progenity
.

Which major investors are selling Progenity stock?

PROG stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, and Dupont Capital Management Corp.
View insider buying and selling activity for Progenity
or view top insider-selling stocks.

Which major investors are buying Progenity stock?

PROG stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Perkins Capital Management Inc., Paloma Partners Management Co, Northern Trust Corp, Leonard Rickey Investment Advisors P.L.L.C., Virtu Financial LLC, Bank of New York Mellon Corp, and ExodusPoint Capital Management LP. Company insiders that have bought Progenity stock in the last two years include Athyrium Capital Management, L, Damon Silvestry, Harry Stylli, and Jeffrey D Alter.
View insider buying and selling activity for Progenity
or or view top insider-buying stocks.

How do I buy shares of Progenity?

Shares of PROG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Progenity's stock price today?

One share of PROG stock can currently be purchased for approximately $3.99.

How much money does Progenity make?

Progenity has a market capitalization of $217.94 million.

How many employees does Progenity have?

Progenity employs 702 workers across the globe.

What is Progenity's official website?

The official website for Progenity is www.progenity.com.

Where are Progenity's headquarters?

Progenity is headquartered at 4330 LA JOLLA VILLAGE DRIVE SUITE 200, SAN DIEGO CA, 92122.

How can I contact Progenity?

Progenity's mailing address is 4330 LA JOLLA VILLAGE DRIVE SUITE 200, SAN DIEGO CA, 92122. The company can be reached via phone at 855-293-2639 or via email at [email protected]


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.